
Sign up to save your podcasts
Or
On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma, about its approach to Acute Myeloid Leukemia, also known as AML. Then, Dr. Nik Sopko, the chief scientific officer of PolarityTE, talked about their design for wound healing. Their first treatment candidate is diabetic foot ulcers, and Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.
4.4
6060 ratings
On this week’s Tech Nation, Moira speaks with Dr. Robert Ang, the President & CEO of Vor Biopharma, about its approach to Acute Myeloid Leukemia, also known as AML. Then, Dr. Nik Sopko, the chief scientific officer of PolarityTE, talked about their design for wound healing. Their first treatment candidate is diabetic foot ulcers, and Dr. Eric Vivier from Innate Pharma in Marseilles tells us about the next wave of immunotherapy treatments – harnessing Natural Killer cells.
6,243 Listeners
697 Listeners
465 Listeners
930 Listeners
38,557 Listeners
43,954 Listeners
90,407 Listeners
37,860 Listeners
30,683 Listeners
32,093 Listeners
933 Listeners
43,685 Listeners
385 Listeners
2,117 Listeners
1,609 Listeners